Role for μ-opioid receptor in antidepressant effects of δ-opioid receptor agonist KNT-127.


Journal

Journal of pharmacological sciences
ISSN: 1347-8648
Titre abrégé: J Pharmacol Sci
Pays: Japan
ID NLM: 101167001

Informations de publication

Date de publication:
Mar 2023
Historique:
received: 26 07 2022
revised: 17 12 2022
accepted: 26 12 2022
entrez: 24 2 2023
pubmed: 25 2 2023
medline: 3 3 2023
Statut: ppublish

Résumé

Previous pharmacological data have shown the possible existence of functional interactions between μ- (MOP), κ- (KOP), and δ-opioid receptors (DOP) in pain and mood disorders. We previously reported that MOP knockout (KO) mice exhibit a lower stress response compared with wildtype (WT) mice. Moreover, DOP agonists have been shown to exert antidepressant-like effects in numerous animal models. In the present study, the tail suspension test (TST) and forced swim test (FST) were used to examine the roles of MOP and DOP in behavioral despair. MOP-KO mice and WT mice were treated with KNT-127 (10 mg/kg), a selective DOP agonist. The results indicated a significant decrease in immobility time in the KNT-127 group compared with the saline group in all genotypes in both tests. In the saline groups, immobility time significantly decreased in MOP-KO mice compared with WT mice in both tests. In female MOP-KO mice, KNT-127 significantly decreased immobility time in the TST compared with WT mice. In male MOP-KO mice, however, no genotypic differences were found in the TST after either KNT-127 or saline treatment. Thus, at least in the FST and TST, the activation of DOP and absence of MOP had additive effects in reducing measures of behavioral despair, suggesting that effects on this behavior by DOP activation occur independently of MOP.

Identifiants

pubmed: 36828615
pii: S1347-8613(22)00096-2
doi: 10.1016/j.jphs.2022.12.008
pii:
doi:

Substances chimiques

KNT 127 0
Receptors, Opioid, mu 0
Morphinans 0
Antidepressive Agents 0
Analgesics, Opioid 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

135-141

Informations de copyright

Copyright © 2022 The Authors. Production and hosting by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare no conflict of interest.

Auteurs

Yuki Moriya (Y)

Department of Biological Psychiatry, Tohoku University Graduate School of Medicine, Sendai, Japan; Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.

Yoshiyuki Kasahara (Y)

Department of Biological Psychiatry, Tohoku University Graduate School of Medicine, Sendai, Japan; Department of Maternal and Fetal Therapeutics, Tohoku University Graduate, School of Medicine, Sendai, Japan; Department of Maternal and Child Healthcare Medical Science, Tohoku, University Graduate School of Medicine, Sendai, Japan. Electronic address: kasa@med.tohoku.ac.jp.

Masafumi Shimada (M)

Department of Biological Psychiatry, Tohoku University Graduate School of Medicine, Sendai, Japan.

Yasufumi Sakakibara (Y)

Department of Biological Psychiatry, Tohoku University Graduate School of Medicine, Sendai, Japan; Department of Neurogenetics, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan.

Hideaki Fujii (H)

Laboratory of Medicinal Chemistry, School of Pharmacy, Kitasato University, Tokyo, Japan.

Hiroshi Nagase (H)

International Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, 1-1-1, Tennodai, Tsukuba, Ibaraki, Japan.

Soichiro Ide (S)

Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.

Kazutaka Ikeda (K)

Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.

F Scott Hall (FS)

Department of Pharmacology and Experimental Therapeutics, College of Pharmacy and Pharmaceutical Sciences, University of Toledo, Toledo, OH, USA.

George R Uhl (GR)

Departments of Neurology and Pharmacology, University of Maryland School of Medicine, and VA Maryland Healthcare System, Baltimore, MD, USA.

Ichiro Sora (I)

Department of Biological Psychiatry, Tohoku University Graduate School of Medicine, Sendai, Japan; Department of Psychiatry, Kobe University Graduate School of Medicine, Kobe, Japan. Electronic address: sora@med.kobe-u.ac.jp.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH